7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tocilizumab in adult-onset Still's disease: the Israeli experience.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To describe the Israeli experience of treating adult-onset Still's disease (AOSD) with tocilizumab (TCZ).

          Related collections

          Author and article information

          Journal
          J. Rheumatol.
          The Journal of rheumatology
          0315-162X
          0315-162X
          Feb 2014
          : 41
          : 2
          Affiliations
          [1 ] From the Department of Rheumatology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Department of Rheumatology, Bnai Zion Medical Center, Haifa; Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem; Rheumatology Unit, The Chaim Sheba Medical Center, Tel Hashomer; Rheumatology Unit, Assaf Harofe Medical Center; Rheumatology Unit, Soroka Medical Center, Beer Sheva, Israel.
          Article
          jrheum.130881
          10.3899/jrheum.130881
          24429168
          d5d99efb-8557-447a-91ce-286fd1d2b97f
          History

          ADULT-ONSET STILL’S DISEASE,BIOLOGICS,CYTOKINES,DISEASE-MODIFYING ANTIRHEUMATIC DRUGS,INFLAMMATION

          Comments

          Comment on this article